miR-145-5p Inhibits HER2-Positive Breast Cancer Cells via Targeting ARF6

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Breast cancer is a significant global health concern with complex molecular underpinnings.
• MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
• Understanding specific miRNA functions, like that of miR-145-5p, is vital for therapeutic advancements.

Purpose of the Study:

• To investigate the role of miR-145-5p in inhibiting breast cancer cell growth and migration.
• To identify the target gene, ADP-ribosylation factor 6 (ARF6), modulated by miR-145-5p.
• To elucidate the underlying molecular mechanisms of miR-145-5p action in breast cancer.

Main Methods:

• Bioinformatic analysis of miR-145-5p expression in breast cancer using TCGA database.
• Quantitative reverse transcription PCR (RT-qPCR) on clinical samples and cell lines.
• In vitro assays (CCK-8, scratch, Transwell) to assess cell viability, migration, and invasion upon miR-145-5p manipulation.
• Dual-luciferase reporter assay to confirm direct interaction between miR-145-5p and ARF6 mRNA.

Main Results:

• miR-145-5p expression was significantly reduced in breast cancer tissues, particularly in HER2-positive cases.
• Overexpression of miR-145-5p suppressed breast cancer cell proliferation, migration, and invasion.
• miR-145-5p directly targets the 3'-untranslated region of ARF6 mRNA, inhibiting its expression.

Conclusions:

• miR-145-5p acts as a tumor suppressor in breast cancer by inhibiting proliferation, migration, and invasion via ARF6 targeting.
• The miR-145-5p/ARF6 axis represents a potential novel therapeutic target for breast cancer.
• This miRNA holds promise for accurate diagnosis and effective treatment strategies for breast cancer patients.